IRCT138710041520N1已完成2 期
Evaluation of the therapeutic effects of Mesalazine in patients with chronic idiopathic urticaria
Shiraz University of Medical Sciences - Vice Chancellor for Research Affairs0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 75 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: new cases, the patients without proper control with antihistamines
- •Exclusion Criteria : children under 12y, pregnant ladies or women with breast feeding, underlying diseases, 5-ASA sensitivity, G6PD deficiency
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Evaluation of the role of mesalazine in the treatment of diverticular disease of the colon and irritable colon syndrome: A randomised double blind placebo controlled clinical study - NDIrritable bowel Syndrome Diverticular disease of the colonMedDRA version: 9.1Level: LLTClassification code 10009993MedDRA version: 9.1Level: LLTClassification code 10023004EUCTR2008-004228-22-ITSOFAR SPA
已完成
不适用
Clinical study for the efficacy of mesalazine for the treatment of small bowel injury caused by non-steroidal anti-inflammatory drugs(NSAIDs).Patients with rheumatoid arthritis with anemia taking NSAIDsJPRN-UMIN000005362Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine13
进行中（未招募）
1 期
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D). - Mesalazine for the treatment of IBS-DDiarrhoea-predominant irritable bowel syndromeMedDRA version: 14.0 Level: LLT Classification code 10060849 Term: Diarrhoea predominant irritable bowel syndrome System Organ Class: 10017947 - Gastrointestinal disordersEUCTR2010-018340-14-GBniversity of Nottingham136
已完成
3 期
Clinical efficacy of Mesalazine in patients with diarrhea-dominant irritable bowel syndrome with elevated fecal calprotectin referred to Emam Reza Hospital of Tabriz: a randomized double-blind, placebo-controlled trialIrritable Bowel Syndrome.Irritable bowel syndromeIRCT20151106024901N5Tabriz University of Medical Sciences90
尚未招募
不适用
The efficacy of Mesarazine drugs treatment for clinical relapse in ulcerative colitis patients, compared 3600mg of Asacolo(r) with 4000mg Pentasa(r)lcerative colitisJPRN-UMIN000009937AGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE60